Worldwide Analgesics Industry to 2027 - Featuring Bayer, Novartis International and Pfizer Among Others

DUBLIN, June 14, 2022 /PRNewswire/ -- The "Analgesics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.

The global analgesics market reached a value of US$ 49.02 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 64.59 Billion by 2027, exhibiting a CAGR of 4.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Analgesics, also known as painkillers or pain relievers, are drugs that help in relieving pain without affecting consciousness, altering sensory perception, or blocking nerve impulse conduction. These drugs include paracetamol (known as acetaminophen or simply APAP in North America), nonsteroidal anti-inflammatory drugs (NSAIDs) such as the salicylates, and opioid drugs such as morphine and oxycodone. Analgesics are used for treating pain resulting from physiological injuries, surgeries, phantom aches, inflammation, neuropathic conditions and cancer treatments. Nowadays, rising internet penetration has enabled various e-commerce platforms to collaborate with pharmaceutical manufacturers to deliver drugs like analgesics at the doorstep of consumers.

The primary factor catalyzing the demand for analgesics is the increasing geriatric population. In 2017, between 950-1000 million people were over the age of 60. However, by 2050, these numbers are expected to reach 2100 million, accounting for around 21% of the total global population. As older adults are more vulnerable to chronic and lifestyles diseases, it will significantly contribute to the sales of analgesics.

Apart from this, many leading pharmaceutical companies are continually focusing on clinical advancements in both the delivery and design of analgesic drugs. They are also developing safer opioids with improved side effect profiles and effective pain relief. Moreover, the presence of a strong drug pipeline with efficacious drugs waiting for approvals by the United States Food and Drug Administration (USFDA) is further expected to enhance the use of analgesics across the globe.

Competitive Landscape:

The market has also been examined with the presence of numerous small and large manufacturers who compete in terms of prices and quality.

Some of the leading players are:

• Bayer AG
• Novartis International AG
• GlaxoSmithKline PLC
• Pfizer Inc.
• Johnson & Johnson Pvt. Ltd.
• Reckitt Benckiser (RB) Group PLC
• Endo Pharmaceuticals PLC
• Bristol-Myers Squibb Company
• Eli Lilly and Company
• Sanofi SA

Key Questions Answered in this Report:

• How has the global analgesics market performed so far and how will it perform in the coming years?
• What are the key regional markets?
• What has been the impact of COVID-19 on the global analgesics market?
• What is the breakup of the market on the basis of type?
• What is the breakup of the market on the basis of drug class?
• What is the breakup of the market on the basis of route of administration?
• What is the breakup of the market on the basis of pain type?
• What is the breakup of the market on the basis of application?
• What are the various stages in the value chain of the global analgesics market?
• What are the key driving factors and challenges in the global analgesics market?
• What is the structure of the global analgesics market and who are the key players?
• What is the degree of competition in the global analgesics market?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Analgesics Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Type
5.5 Market Breakup by Drug Class
5.6 Market Breakup by Route of Administration
5.7 Market Breakup by Pain Type
5.8 Market Breakup by Application
5.9 Market Breakup by Region
5.10 Market Forecast

6 Market Breakup by Type
6.1 Prescription
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Over the counter (OTC)
6.2.1 Market Trends
6.2.2 Market Forecast

7 Market Breakup by Drug Class
7.1 Opioids
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 NSAID
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast

8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Topical
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Transdermal
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Rectal
8.5.1 Market Trends
8.5.2 Market Forecast

9 Market Breakup by Pain Type
9.1 Musculoskeletal
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Surgical and Trauma
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cancer
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Neuropathic
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Migraine
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Obstetrical
9.6.1 Market Trends
9.6.2 Market Forecast
9.7 Fibromyalgia
9.7.1 Market Trends
9.7.2 Market Forecast
9.8 Pain due to Burns
9.8.1 Market Trends
9.8.2 Market Forecast
9.9 Dental/Facial
9.9.1 Market Trends
9.9.2 Market Forecast
9.10 Pediatric
9.10.1 Market Trends
9.10.2 Market Forecast
9.11 Others
9.11.1 Market Trends
9.11.2 Market Forecast

10 Market Breakup by Application
10.1 Internal
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 External
10.2.1 Market Trends
10.2.2 Market Forecast

11 Market Breakup by Region

12 Global Analgesics Industry: SWOT Analysis

13 Global Analgesics Industry: Value Chain Analysis

14 Global Analgesics Industry: Porters Five Forces Analysis

15 Global Analgesics Industry: Price Analysis
15.1 Price Indicators
15.2 Price Structure
15.3 Margin Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Bayer AG
16.3.2 Novartis International AG
16.3.3 GlaxoSmithKline PLC
16.3.4 Pfizer Inc.
16.3.5 Johnson & Johnson Pvt. Ltd.
16.3.6 Reckitt Benckiser (RB) Group PLC
16.3.7 Endo Pharmaceuticals PLC
16.3.8 Bristol-Myers Squibb Company
16.3.9 Eli Lilly and Company
16.3.10 Sanofi SA

For more information about this report visit https://www.researchandmarkets.com/r/g16buq

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets